Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cells
Erin R. Scheidemann(Georgetown University), Ayesha N. Shajahan‐Haq(Georgetown University)
Cited by 2
Related Papers
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
|Frontiers in Oncology|2021|30